Long-Term Outcomes of Submaximal Activities of Peptide Receptor Radionuclide Therapy with 177Lu-DOTATATE in Neuroendocrine Tumor Patients

Noémie S. Minczeles*, Wouter W. de Herder, Richard A. Feelders, Frederik A. Verburg, Johannes Hofland, Tessa Brabander

*Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

3 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Long-Term Outcomes of Submaximal Activities of Peptide Receptor Radionuclide Therapy with 177Lu-DOTATATE in Neuroendocrine Tumor Patients'. Together they form a unique fingerprint.

Medicine and Dentistry